Literature DB >> 34616164

Productivity Loss and Associated Costs Among Patients with Transfusion-Dependent Thalassemia in Dubai, United Arab Emirates.

Shaikha Alshamsi1, Samer Hamidi2, Hacer Ozgen Narci3.   

Abstract

OBJECTIVE: The aim of this study was to assess the indirect burden of patients with transfusion-dependent thalassemia (TDT) in Dubai, the United Arab Emirates (UAE).
METHODS: Adult patients with TDT were enrolled during blood transfusion sessions. Productivity loss for patients in the preceding four weeks was reported using the validated iMTA Productivity Cost Questionnaire (iPCQ).
RESULTS: A total of 161 adult patients with TDT were included in the study. The annual total productivity loss cost at paid work among 79 employed patients was AED 17,230 (USD 4691) (95% CI: 12,302-22,159), out of which absenteeism contributed AED 10,328 (USD 2812) and presenteeism contributed AED 6902 (USD 1879), whereas the annual total productivity loss cost at unpaid work was AED 4053 (USD 1104) (95% CI: 3471-4661). The annual mean total indirect cost for paid and unpaid work was AED 21,283 (USD 5795). Monthly income, nationality, and having two and more disease complications were the significant predictors of higher productivity loss costs. Having previously had a splenectomy was a negative and significant predictor of productivity loss costs.
CONCLUSION: TDT was associated with substantial productivity loss and indirect costs in the UAE. Health policies that aim to control transfusion-dependent thalassemia effectively are necessary and could result in cost savings for patients and employers.
© 2021 Alshamsi et al.

Entities:  

Keywords:  Dubai; United Arab Emirates; friction cost approach; productivity loss; transfusion-dependent thalassemia

Year:  2021        PMID: 34616164      PMCID: PMC8487795          DOI: 10.2147/CEOR.S334724

Source DB:  PubMed          Journal:  Clinicoecon Outcomes Res        ISSN: 1178-6981


  19 in total

Review 1.  Thalassemia--a global public health problem.

Authors:  D J Weatherall; J B Clegg
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

Review 2.  Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review.

Authors:  Jamison Pike; Scott D Grosse
Journal:  Appl Health Econ Health Policy       Date:  2018-12       Impact factor: 2.561

3.  Global epidemiology of haemoglobin disorders and derived service indicators.

Authors:  Bernadette Modell; Matthew Darlison
Journal:  Bull World Health Organ       Date:  2008-06       Impact factor: 9.408

4.  alpha-thalassemia in the United Arab Emirates.

Authors:  S El-Kalla; E Baysal
Journal:  Acta Haematol       Date:  1998       Impact factor: 2.195

5.  Indirect costs of rheumatoid arthritis in Brazil.

Authors:  Ana Beatriz Cordeiro de Azevedo; Marcos Bosi Ferraz; Rozana Mesquita Ciconelli
Journal:  Value Health       Date:  2008-05-16       Impact factor: 5.725

6.  The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.

Authors:  Clazien Bouwmans; Marieke Krol; Hans Severens; Marc Koopmanschap; Werner Brouwer; Leona Hakkaart-van Roijen
Journal:  Value Health       Date:  2015-08-20       Impact factor: 5.725

7.  A scoring system for the classification of beta-thalassemia/Hb E disease severity.

Authors:  Orapan Sripichai; Wattanan Makarasara; Thongperm Munkongdee; Chutima Kumkhaek; Issarang Nuchprayoon; Ampaiwan Chuansumrit; Suporn Chuncharunee; Nawarat Chantrakoon; Piathip Boonmongkol; Pranee Winichagoon; Suthat Fucharoen
Journal:  Am J Hematol       Date:  2008-06       Impact factor: 10.047

8.  Thalassemia in the United Arab Emirates: Why it can be prevented but not eradicated.

Authors:  Sehjeong Kim; Abdessamad Tridane
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

9.  Economic Burden of Thalassemia Major in Iran, 2015.

Authors:  Firooz Esmaeilzadeh; Azita Azarkeivan; Sara Emamgholipour; Ali Akbari Sari; Mehdi Yaseri; Batoul Ahmadi; Mohtasham Ghaffari
Journal:  J Res Health Sci       Date:  2016

10.  Expenditure to treat thalassaemia: an experience at a tertiary care hospital in India.

Authors:  S Mallik; C Chatterjee; Pankaj K Mandal; Jadab C Sardar; P Ghosh; N Manna
Journal:  Iran J Public Health       Date:  2010-03-31       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.